Solaplus Biotech Co., Ltd. · Class U · Cleared Aug 28, 2020
| K-number | K192671 |
| Device name | Hemostatic Xerogel Sponge |
| Applicant | Solaplus Biotech Co., Ltd. |
| Product code | QSY |
| Device class | Class U |
| Decision date | Aug 28, 2020 |
| Decision | Substantially Equivalent |
| Regulation | — |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov